
AI and Health: Discussing The New Perimeter of Decision-Making in Rome
Aindo hosted a strategic dialogue between institutions, industry, and research to define the future of data governance and regulatory access.
News on Aindo Synth v3.1

We are proud to announce the release of the new version of the Aindo’s Synthetic Data Platform, Aindo Synth. We worked closely with end-users in healthcare, finance, and insurance to determine key synthetic data needs. With the new release, we meet these needs with an innovative, easy to use and efficient platform.
Particular novelties include:
To find out more about Aindo Synth 3.1, see our recent blog entries and the documentation.
Italian Patent No. 102021000008552 ↩
Daniele Panfilo, (2022). Generating Privacy-Compliant, Utility-Preserving Synthetic Tabular and Relational Datasets Through Deep Learning. University of Trieste. ↩
Ciro A. Mami, Andrea Coser, Eric Medvet, Alexander T.P. Boudewijn, Marco Volpe, Michael Whitworth, Borut Svara, Gabriele Sgroi, Daniele Panfilo and Sebastiano Saccani (2022). Generating Realistic Synthetic Relational Data through Graph Variational Autoencoders. Proceedings of the Thirty-sixth Conference on Neural Information Processing Systems (NeurIPS). ↩

Aindo hosted a strategic dialogue between institutions, industry, and research to define the future of data governance and regulatory access.

Aindo hosted a strategic dialogue between institutions, industry, and research to define the future of data governance and regulatory access.

Aindo and IQVIA Italy join forces to scale synthetic data adoption in the Italian healthcare ecosystem.